NIH-funded research U01 cooperative agreement

Surgery, stenting, or medicine for people with severe carotid artery narrowing who have no symptoms

Official title: Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2)

Funded at Mayo Clinic Jacksonville · NIH-11193054 · Data updated 2026-11-12

This project compares adding carotid surgery or artery stents to intensive medical treatment versus intensive medical treatment alone for people with severe narrowing of the carotid artery who have not had symptoms.

More Carotid Stenosis research and trials

Quick facts

Grant typeU01 cooperative agreement
Study typeNIH-funded research
Funding institutionMayo Clinic Jacksonville
NIH-funded
Lab location1 site (Jacksonville, United States)
Project startMarch 15, 2014
Project endAugust 31, 2026
Funding year2025
Award (this year)$156,497
NIH project number3U01NS080168-12S1
Project IDNIH-11193054 on NIH RePORTER

Who could benefit from this research

Could help

Adults with high-grade (severe) asymptomatic carotid artery narrowing who meet surgical and medical eligibility criteria are the ideal candidates.

Less likely to help

People with symptomatic carotid disease, low-grade narrowing, or who are not candidates for surgery or stenting would not be expected to benefit directly from this project.

What this research studies

If you have severe narrowing of a carotid artery but no recent stroke or warning symptoms, this project randomly assigns people to get intensive medical care alone or to get intensive medical care plus either carotid surgery or carotid stenting. Participants are followed over time for stroke, complications, and overall health. The work runs in parallel: one arm compares surgery plus medicine to medicine alone and the other compares stenting plus medicine to medicine alone. The trial has enrolled thousands of patients at many U.S. and international sites and used a mix of on-site and remote monitoring, especially during the COVID-19 period.

Why it matters

Potential benefit: If successful, the results could clarify which approach best prevents stroke and help people avoid unnecessary procedures.

How similar studies have gone: Earlier trials, including the original CREST trial, compared stenting and surgery and informed safety and outcomes, but CREST-2 is testing whether adding revascularization to modern intensive medical care provides extra stroke prevention.

Where this research is happening

  • Mayo Clinic Jacksonville
    Jacksonville, United States
    Active

Researchers

  • Principal investigator: Brott, Thomas G — Mayo Clinic Jacksonville
  • Study coordinator: Brott, Thomas G

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.